Dataset from Frequent Hemodialysis Network: Daily Trial

The Frequent Hemodialysis Network (FHN) Daily Trial is a randomized controlled trial
recruiting subjects from dialysis units associated with designated Clinical Centers in the
U.S. and Canada and followed for 1 year. Subjects will be randomized to either conventional
hemodialysis Daily HD delivered for at least 2.5 hours (typically 3 to 4 hours), 3 days per
week, or to more frequent hemodialysis delivered for 1.5 - 2.75 hours, 6 days per week. The
study has two co-primary outcomes: 1) a composite of mortality with the change over 12 months
in left ventricular mass by magnetic resonance imaging, and 2) a composite of mortality with
the change over 12 months in the SF-36 RAND physical health composite (PHC) quality of life
scale.